HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Valet Selected Research

Hyperglycemia

6/2016Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia.
2/2014Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes.
9/2011Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice.
10/2005Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Valet Research Topics

Disease

30Obesity
01/2022 - 05/2003
23Insulin Resistance
08/2022 - 04/2005
19Neoplasms (Cancer)
01/2024 - 04/2011
17Inflammation (Inflammations)
11/2021 - 07/2006
8Body Weight (Weight, Body)
01/2019 - 02/2007
6Type 2 Diabetes Mellitus (MODY)
01/2020 - 06/2010
6Breast Neoplasms (Breast Cancer)
01/2019 - 02/2011
6Fibrosis (Cirrhosis)
01/2018 - 12/2007
6Hyperinsulinism (Hyperinsulinemia)
02/2014 - 04/2005
5Metabolic Diseases (Metabolic Disease)
01/2019 - 02/2011
4Hypoxia (Hypoxemia)
06/2017 - 07/2010
4Hyperglycemia
06/2016 - 10/2005
4Glucose Intolerance
08/2012 - 03/2007
3Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2021 - 03/2012
3Hypertrophy
01/2019 - 06/2010
3Overweight
01/2018 - 04/2010
3Cardiomegaly (Heart Hypertrophy)
01/2017 - 06/2010
2Fatty Liver
03/2022 - 05/2008
2Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 01/2017
2Prostatic Neoplasms (Prostate Cancer)
02/2021 - 01/2016
2Weight Loss (Weight Reduction)
01/2021 - 06/2008
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2016
2Thrombosis (Thrombus)
12/2019 - 02/2016
2Sarcopenia
01/2019 - 01/2018
2Myocardial Infarction
01/2018 - 06/2017
2Heart Failure
01/2018 - 09/2012
2Ventricular Dysfunction
01/2013 - 09/2012
2Hyperphagia (Overeating)
08/2012 - 03/2007
1Lymphedema (Milroy Disease)
01/2024
1Emergence Delirium
01/2023
1Adenocarcinoma
09/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2022
1Colorectal Neoplasms (Colorectal Cancer)
05/2022
1Non-alcoholic Fatty Liver Disease
03/2022
1Diabetes Mellitus
01/2022
1Neoplasm Metastasis (Metastasis)
02/2021

Drug/Important Bio-Agent (IBA)

36ApelinIBA
01/2024 - 04/2005
22Glucose (Dextrose)FDA LinkGeneric
09/2022 - 10/2005
13Insulin (Novolin)FDA Link
01/2018 - 04/2005
11LipidsIBA
11/2021 - 02/2007
10AdipokinesIBA
01/2022 - 04/2005
8CytokinesIBA
01/2022 - 12/2007
7Proteins (Proteins, Gene)FDA Link
09/2022 - 05/2003
6Messenger RNA (mRNA)IBA
01/2024 - 01/2011
6Peptides (Polypeptides)IBA
01/2019 - 11/2011
5Apelin ReceptorsIBA
09/2022 - 06/2010
5CholesterolIBA
01/2022 - 04/2010
5CollagenIBA
01/2021 - 01/2014
4Tyrosine (L-Tyrosine)FDA Link
08/2022 - 03/2012
4Triglycerides (Triacylglycerol)IBA
01/2021 - 02/2012
4Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 02/2012
4EnzymesIBA
01/2020 - 03/2004
4Nonesterified Fatty Acids (NEFA)IBA
01/2019 - 04/2014
4Peptide Hydrolases (Proteases)FDA Link
01/2016 - 02/2011
4lysophosphatidic acidIBA
01/2014 - 12/2007
3Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
08/2022 - 03/2012
3AminesIBA
02/2021 - 08/2007
3Blood Glucose (Blood Sugar)IBA
01/2018 - 04/2010
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017 - 12/2007
3Interleukin-6 (Interleukin 6)IBA
01/2014 - 04/2011
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2013 - 03/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2011 - 02/2010
2Vascular Endothelial Growth Factor CIBA
01/2024 - 06/2017
2CateninsIBA
09/2022 - 09/2013
2ChemokinesIBA
02/2021 - 05/2008
2Oxidoreductases (Dehydrogenase)IBA
02/2021 - 08/2007
2human AOC3 proteinIBA
02/2021 - 12/2010
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 02/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 06/2010
2Hormones (Hormone)IBA
11/2018 - 07/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2017 - 07/2010
2Glucagon-Like Peptide 1 (GLP 1)IBA
02/2014 - 10/2008
2LipopolysaccharidesIBA
02/2014 - 05/2008
2Drinking WaterIBA
01/2014 - 04/2010
22,4-dinitrofluorobenzene sulfonic acidIBA
01/2014 - 03/2011
2LeptinIBA
01/2014 - 05/2008
23- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA
01/2014 - 12/2007
2Conditioned Culture MediaIBA
09/2013 - 12/2007
2Monoamine Oxidase (MAO)IBA
01/2013 - 03/2004
2Nitric Oxide Synthase (NO Synthase)IBA
05/2012 - 02/2010
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
11/2011 - 03/2011
2Phosphotransferases (Kinase)IBA
07/2011 - 03/2011
2benzylamineIBA
12/2010 - 04/2010
2Phospholipids (Phosphatides)FDA LinkGeneric
09/2008 - 12/2007
2Lysophosphatidic Acid ReceptorsIBA
09/2008 - 12/2007
2Connective Tissue Growth FactorIBA
09/2008 - 12/2007
1RNA (Ribonucleic Acid)IBA
01/2024
1Cyclin D1IBA
09/2022
1Calcibiotic Root Canal SealerIBA
05/2022
1HMGB1 Protein (HMG1)IBA
03/2022
1Liver X ReceptorsIBA
03/2022
1CreatinineIBA
01/2022
1ProgranulinsIBA
01/2022
1Leukocyte Elastase (Neutrophil Elastase)IBA
11/2021
1cathepsin SIBA
11/2021
1Chemokine ReceptorsIBA
02/2021
1F8 monoclonal antibodyIBA
01/2021

Therapy/Procedure

7Therapeutics
09/2022 - 02/2010
2Institutionalization (Institutionalized Persons)
01/2023 - 01/2018
1Endurance Training
01/2021